1. Home
  2. SLNO vs RNST Comparison

SLNO vs RNST Comparison

Compare SLNO & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLNO
  • RNST
  • Stock Information
  • Founded
  • SLNO 1999
  • RNST 1904
  • Country
  • SLNO United States
  • RNST United States
  • Employees
  • SLNO N/A
  • RNST N/A
  • Industry
  • SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • RNST Major Banks
  • Sector
  • SLNO Health Care
  • RNST Finance
  • Exchange
  • SLNO Nasdaq
  • RNST Nasdaq
  • Market Cap
  • SLNO 3.8B
  • RNST 3.3B
  • IPO Year
  • SLNO 2014
  • RNST N/A
  • Fundamental
  • Price
  • SLNO $86.00
  • RNST $35.48
  • Analyst Decision
  • SLNO Strong Buy
  • RNST Buy
  • Analyst Count
  • SLNO 9
  • RNST 6
  • Target Price
  • SLNO $105.11
  • RNST $42.20
  • AVG Volume (30 Days)
  • SLNO 1.5M
  • RNST 624.8K
  • Earning Date
  • SLNO 08-06-2025
  • RNST 07-22-2025
  • Dividend Yield
  • SLNO N/A
  • RNST 2.48%
  • EPS Growth
  • SLNO N/A
  • RNST N/A
  • EPS
  • SLNO N/A
  • RNST 2.24
  • Revenue
  • SLNO N/A
  • RNST $735,631,000.00
  • Revenue This Year
  • SLNO N/A
  • RNST $41.67
  • Revenue Next Year
  • SLNO $506.77
  • RNST $12.79
  • P/E Ratio
  • SLNO N/A
  • RNST $15.88
  • Revenue Growth
  • SLNO N/A
  • RNST 17.24
  • 52 Week Low
  • SLNO $41.50
  • RNST $26.97
  • 52 Week High
  • SLNO $90.32
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • SLNO 54.38
  • RNST 39.21
  • Support Level
  • SLNO $83.53
  • RNST $35.79
  • Resistance Level
  • SLNO $89.12
  • RNST $37.92
  • Average True Range (ATR)
  • SLNO 2.65
  • RNST 0.89
  • MACD
  • SLNO -0.34
  • RNST -0.34
  • Stochastic Oscillator
  • SLNO 56.91
  • RNST 8.39

About SLNO Soleno Therapeutics Inc.

Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: